Mukka Proteins Limited has completed the acquisition of a 51% stake in Delta Marine Products, a partnership firm, for ₹11.10 crore. The transaction was executed through capital contribution on June 25, 2026, as part of the company's strategic investment plans to expand its core business. This acquisition is expected to enhance production efficiency and broaden market reach through capacity expansion and optimization of operational processes.

The disclosure was submitted to the National Stock Exchange of India and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the acquisition does not constitute a related party transaction and that no specific governmental or regulatory approvals were required for the completion of the deal.

Delta Marine Products operates in the manufacturing sector, specifically producing fish meal and fish oil. The entity was incorporated on August 12, 2023, and operates solely within India. The acquisition provides Mukka Proteins with controlling interest in the firm, aligning with its objective to strengthen its position in the fish meal and fish oil market.

The financial performance of Delta Marine Products shows significant growth in turnover over the past year. The firm reported a turnover of ₹28,16,99,338 for FY 2024-25, compared to ₹3,64,15,650 in the previous fiscal year ending March 2024. However, the entity recorded a Profit After Tax (PAT) of ₹(19,72,919) for FY 2024-25.

Financial Overview of Delta Marine Products

The consideration for the acquisition was paid entirely in cash. The investment is intended to drive operational synergies and support the strategic growth initiatives of Mukka Proteins in the manufacturing of steam dried fish meal, fish oil, and fish soluble paste.

Mukka Proteins Limited has submitted an application to BSE Limited and National Stock Exchange of India Limited seeking in-principle approval for the preferential allotment of 2,00,00,000 (Two Crore) fully convertible warrants. The warrants are priced at ₹23.50 each, comprising a face value of ₹1 and a premium of ₹22.50, aggregating up to ₹47,00,00,000. The proposed issue is subject to shareholder approval via a postal ballot and other regulatory clearances. The proceeds are intended to meet working capital requirements, fund business expansion, and for general corporate purposes.

The Board of Directors approved the proposal on June 12, 2026. The issue price is supported by a valuation report from Ms. Kavita Joshi, a Registered Valuer, and is not lower than the minimum price determined under SEBI ICDR Regulations. Each warrant is convertible into one equity share within 18 months from the date of allotment. The subscription requires an upfront payment of 25%, with the remaining 75% payable upon exercise. Warrants not exercised within 18 months will lapse, and the amount paid will be forfeited.

E-Voting Schedule and Process

Shareholders can vote through the CDSL e-voting system during the designated period. Physical copies of the postal ballot notice will not be dispatched. The company has appointed Mr. Chethan Nayak K and Mrs. Ujala Rani of Chethan Nayak & Associates as scrutinizers for the process.

Proposed Allottees

The warrants are proposed to be allotted to 15 identified individuals and entities in the non-promoter category. The table below details the maximum number of warrants proposed for each allottee.